Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II PK and Safety Study of KRP-AB1102F DPI in COPD
jRCT2080222176Phase 2
- Sponsor
- Kyorin Pharmaceutical
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of KRP-AB1102F in chronic obstructive pulmonary disease (COPD), sponsored by Kyorin Pharmaceutical. Primary endpoints: Pharmacokinetics of KRP-AB1102F DPI and Safety and tolerability of KRP-AB1102F DPI.
02
Drugs
KRP-AB1102F
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT2080222176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222176.